The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event.

The attendees will learn more about the new Australian consensus; treatment goals for moderate to severe psoriasis in the era of targeted therapies and how these groundbreaking “recommendations” have the potential to transform the landscape of psoriasis care. You will learn how advanced targeted therapies fit into the guidelines, providing highly effective and personalised solutions for patients.

At the Victorian event, A/Prof Peter Foley and A/Prof Chris Baker will lead the discussion and present the Australasian Dermatology Registry, particularly exploring the exciting advantages of this new Registry and the opportunities it presents for earning Category 3 CPD.

Don’t miss out on this engaging discussion that promises to unveil the future of psoriasis treatment and professional development. We invite you to be a part of this informative dinner meeting! Limited spots are available!